United States· US:23155-517_f5ff3a0f-57f7-46cc-9c90-0499e02c3e7f
Neostigmine Methylsulfate
A medicinal product containing neostigmine methylsulfate, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOSTIGMINE METHYLSULFATE
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1123155-517-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neostigmine methylsulfate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyNeostigCarinopharm Gmbh
- CanadaNEOSTIGMINE METHYLSULFATE INJECTION USPMARCAN PHARMACEUTICALS INC
- BelgiumProstigmine 0.5 mg/mlViatris Healthcare
- NetherlandsNeostigminemethylsulfaat CF 0,5 mg/ml, injectievloeistofCentrafarm B.V.
- FranceNEOSTIGMINE RENAUDIN 5 mg/5 mL, solution injectableLABORATOIRE RENAUDIN
- NorwayNeostig-carinopharmCarinopharm
- PolandPolstigminumTeva Pharmaceuticals Polska Sp. z o.o.
- CzechiaSYNTOSTIGMINBB Pharma a.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Neostig, Normastigmin
- Cyprus · Neostigmine Cooper
- Czechia · Syntostigmin
- Germany · Neostig, Neostigmin Panpharma
- Spain · Neostigmina Braun
- France · Néostigmine Renaudin, Prostigmine
- United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
- Greece · Neostigmine Cooper
- Croatia · Neostigmin Panpharma
- Hungary · Neostigmine Kalceks, Stigmosan
- Latvia · Neostigmine Kalceks
- Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
- Poland · Polstigminum
- Portugal · Neostigmina Braun
- Romania · Miostin
- Sweden · Neostigmin Unimedic Pharma Ab
- Slovakia · Syntostigmin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8dd2f9e-fa46-46f6-9206-282f7e0773a4 GET /v1/drugs/b8dd2f9e-fa46-46f6-9206-282f7e0773a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": ".5",
"substance": "NEOSTIGMINE METHYLSULFATE",
"productndc": "23155-517",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA208230",
"marketing_category": "ANDA"
}See everything about neostigmine methylsulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.